Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.       Anmelden     oder      Jetzt abonnieren!

Archiv: Unternehmen

Bystronic passt Ausblick für das Geschäftsjahr 2026 an » Report
Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer » Report
Partners Group statement regarding its evergreen vehicles » Report
Novartis RemIND data at EAACI show Rhapsido® potential as first targeted therapy for chronic inducible urticaria (CIndU) » Report
Interroll Annual General Meeting 2026: Shareholders approve all proposals » Report
ECB PRESS RELEASE Monetary policy decisions » Report
EZB PRESSEMITTEILUNG Geldpolitische Beschlüsse » Report
Partners Group targets USD 1.5 billion for latest real estate secondaries program » Report
FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer » Report
Novartis delpacibart braxlosiran (del-brax) Phase I/II study in facioscapulohumeral muscular dystrophy (FSHD) meets primary biomarker endpoint » Report
FDA grants Priority Review for Roche’s Tecentriq for a certain type of stage III colon cancer » Report
Mikron hosts the H1 2026 results media and analysts webcast on July 17, 2026 » Report
DKSH Enters Strategic Distribution Partnership with BridgeBio to Support Regulatory Evaluation and Potential Patient Access to Transthyretin Stabilizer for ATTR-CM in Selected Asia Pacific Markets » Report
HBM Healthcare Investments profitiert vom erfolgreichen Börsengang von Parabilis Medicines » Report
Implenia renforce ses compétences en ingénierie et en planification en reprenant Zigmo Engineering » Report
Implenia stärkt Engineering- und Planungskompetenzen durch Übernahme von Zigmo Engineering » Report
Curatis Increases Revenue Growth Guidance for 2026 » Report
Zurich Airport Key traffic figures May 2026 » Report
Flughafen Zürich Verkehrszahlen Mai 2026 » Report
FDA News Release: FDA Expands Sunscreen Options for the First Time in 20 Years » Report